2018 (analysis) : Reclassification suggestion for psilocybin In an evaluation of the safety and abuse analysis on the drug in hallucinogenic mushrooms, Johns Hopkins scientists advise that if it clears phase III medical https://psychedelicmushroomstores.com/product-category/microdose-capsules/